Amy S. Butler
Corporate Officer/Principal chez The International Union of Basic & Clinical Pharmacology
Postes actifs de Amy S. Butler
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| The International Union of Basic & Clinical Pharmacology | Corporate Officer/Principal | - | - |
Historique de carrière de Amy S. Butler
Anciens postes connus de Amy S. Butler
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Celentyx Ltd.
 Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Royaume-Uni | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Celentyx Ltd.
Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Health Technology |
| The International Union of Basic & Clinical Pharmacology |
- Bourse
- Insiders
- Amy S. Butler
- Expérience
